Oct 29, 2007
Should drugs be open access? What about open source? Well, a step towards what some would sees as a utopia and others as the end of pharma R&D, could soon be taken with a proposed legislative bill in the US that seeks to make all pharmaceutical patents public domain.
There are some observers that suggest the existence of a patents culture in the pharma industry stifles research and development. Nobel Prize winning economist, Joseph …
Jul 24, 2007
John Wilbanks, executive director of the Science Commons, and his colleagues are now focusing on access to the literature, obtaining materials, and sharing data. Science Commons recently introduced a set of tools to allow authors greater control over papers published in scientific journals.
This week, they have launched the Neurocommons project, an open-source research platform for brain studies. This system uses text-mining tools and analysis software to annotate millions of neurology papers, so that researchers worldwide …
Jun 15, 2007
A rather eye-catching paper was posted on the ChemRank site recently entitled: How to write consistently boring scientific literature. The paper is a parody on the art of writing a research paper by biologist Kaj Sand-Jensen of the University of Copenhagen. And begins, “Although scientists typically insist that their research is very exciting and adventurous when they talk to laymen and prospective students, the allure of this enthusiasm is too often lost in the predictable, …
« Previous Page — « Previous entries « Previous Page · Next Page » Next entries » — Next Page » Blog Archives »
Sciencebase FAQ
Contact me